Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00432809 · ClinicalTrials.gov registry record · NA

Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes

A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT00432809: Completed NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by The Cleveland Clinic.

NCT00432809 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by The Cleveland Clinic. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00432809, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to compare the relative clinical outcomes between advanced medical therapy alone or advanced medical therapy combined with bariatric surgery \[either Roux-en-Y gastric bypass (RYGBP) or laparoscopic sleeve gastrectomy\] in patients with type 2 diabetes and a body mass index (BMI) between 27 and 43 kg/m2. The study will examine the short and long term effects of each intervention on biochemical resolution of diabetes, diabetic complications, and end-organ damage.

Primary Outcome

The proportion of subjects with a glycated hemoglobin level of 6% or less(with or without diabetes medications) 12 months after randomization (baseline measure).

Interventions

  • PROCEDURE Sleeve Gastrectomy
  • PROCEDURE Gastric bypass

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2007-02
Est. Completion 2016-09
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT00432809 record still lists

NCT00432809 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Sleeve Gastrectomy is the first listed.

NCT00432809 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00432809 about?

NCT00432809 is a clinical study titled "Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes". The aim of the study is to compare the relative clinical outcomes between advanced medical therapy alone or advanced medical therapy combined with bariatric surgery \[either Roux-en-Y gastric bypass (RYGBP) or laparoscopic sleeve gastrectomy\] in patients with type 2 diabetes and a body mass index (...

What is the current status of trial NCT00432809?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2007-02. Estimated completion is 2016-09.

What conditions does trial NCT00432809 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00432809?

The interventions under investigation include: Sleeve Gastrectomy (PROCEDURE), Gastric bypass (PROCEDURE).

Who is sponsoring clinical trial NCT00432809?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00432809 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00432809's enrollment target sits among peer trials

150 370th of 1053 higher than 668 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00432809, the US trial registry maintained by the National Library of Medicine. NCT00432809 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.